Open AccessPrevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt
Author(s) -
Amira M. El-Ganiny,
Nehal E. Yossef,
Hend A Kamel
Publication year - 2021
Publication title -
current medical mycology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.369
H-Index - 6
eISSN - 2423-3439
pISSN - 2423-3420
DOI - 10.18502/cmm.7.1.6181
Subject(s) - caspofungin , fluconazole , candida dubliniensis , microbiology and biotechnology , candida tropicalis , candida glabrata , candida krusei , voriconazole , biology , amphotericin b , candida albicans , drug resistance , candida auris , corpus albicans , antifungal
There is a significant rise in morbidity and mortality of infections caused by Candida . Candida spp. infections are currently ranked fourth among nosocomial infections which are difficult to diagnose and refractory to therapy. Given the differences in susceptibility among various spp., identification of Candida spp. is an important step that leads to the selection of a suitable antifungal.